The spiraling cost of medicines will be the focus at a major conference in Dublin today.
The 'Access to Medicines' event will see patient advocates, business leaders and pharmaceutical companies discuss the effects high drug prices have on healthcare systems and patients.
Orkambi, Spinraza and Pembro are just some of the drugs Irish patients have had trouble accessing in recent years.
James Love is an expert on competition policy.
He says the current system is the problem: